- Wondering if GE HealthCare Technologies at around US$71.54 is offering value or just noise in a complex market? This article breaks down what the current price might be implying.
- Over shorter periods the stock has been mixed, with a 1.6% gain over the last 7 days, a 14.9% decline over 30 days, and a 13.6% decline year to date, while the 1 year return stands at a 12.2% decline.
- These moves have kept investors focused on what might be driving sentiment around GE HealthCare Technologies, from broader sector attention on medical technology to ongoing interest in large established healthcare names. While this article does not hinge on a specific catalyst, it uses these price shifts as a backdrop for thinking about what the current valuation could be signaling today.
- On Simply Wall St's valuation checks, GE HealthCare Technologies scores a full 6 out of 6. The sections that follow will walk through standard valuation methods before finishing with a more holistic way to think about what this score might mean for you.
Approach 1: GE HealthCare Technologies Discounted Cash Flow (DCF) Analysis
A DCF model takes projected future cash flows and then discounts them back to today to estimate what the business might be worth right now. For GE HealthCare Technologies, the model uses a 2 Stage Free Cash Flow to Equity approach built on cash flow projections.
The latest twelve month Free Cash Flow is about $1.55b. Analysts provide estimates out to 2028, with Simply Wall St extending these further using its own assumptions. By 2035, the model is using an extrapolated Free Cash Flow figure of roughly $3.65b, with each year discounted back to today and summed.
Putting those discounted values together, the DCF model arrives at an estimated intrinsic value of about $113.35 per share. Against a current share price around $71.54, this implies the stock is 36.9% undervalued based on these cash flow assumptions.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests GE HealthCare Technologies is undervalued by 36.9%. Track this in your watchlist or portfolio, or discover 61 more high quality undervalued stocks.
Approach 2: GE HealthCare Technologies Price vs Earnings (P/E)
For a profitable company like GE HealthCare Technologies, the P/E ratio is a useful shorthand for how much you are paying for each dollar of earnings. Investors typically accept a higher P/E when they see stronger growth potential or lower perceived risk, while slower growth or higher uncertainty tends to justify a lower, more conservative multiple.
GE HealthCare Technologies currently trades on a P/E of about 15.7x. This sits below the Medical Equipment industry average P/E of roughly 27.7x and below the broader peer group average of about 30.2x. Simply Wall St also calculates a proprietary “Fair Ratio” for the stock of around 28.9x, which reflects factors such as earnings growth profile, industry, profit margins, company size and specific risks.
The Fair Ratio aims to be more tailored than a simple comparison with industry or peers, because it adjusts for the characteristics of GE HealthCare Technologies rather than treating all companies as if they deserve the same multiple. Comparing the Fair Ratio of 28.9x with the current P/E of 15.7x suggests the shares are trading below what this framework would indicate.
Result: UNDERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Upgrade Your Decision Making: Choose your GE HealthCare Technologies Narrative
Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St give you a simple story behind your numbers, letting you set assumptions for GE HealthCare Technologies revenue, earnings and margins, link that story to a forecast and Fair Value, and then compare it to the current price to decide whether the gap justifies action. Narratives on the Community page update automatically as news or earnings arrive and capture very different views, such as one investor building a story that supports a Fair Value closer to the higher analyst target of US$106.00 while another leans toward the lower end around US$73.00.
Do you think there's more to the story for GE HealthCare Technologies? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com